Centessa Pharmaceuticals (CNTA) Insider Trading & Ownership → No experience to confident trader, meet my student… (From Wealth Builders Institute) (Ad) Free cnta Stock Alerts $9.25 -0.22 (-2.32%) (As of 05/6/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.54%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$942,882.86 Get CNTA Insider Trade Alerts Want to know when executives and insiders are buying or selling Centessa Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CNTA Insider Buying and Selling by Quarter Ad DTIThe best inflation-proof investment The markets are CRAZY right now. Which is why thousands of investors are flocking into one little-known company. Click here for the full story Centessa Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/25/2024Karen M AndersonInsiderSell51,160$11.88$607,780.80 2/1/2024Harris RotmanSVPSell4,267$8.10$34,562.70 9/20/2023Harris RotmanSVPSell37,484$6.29$235,774.36 6/1/2023Antoine YverEVPSell6,500$4.45$28,925.00 5/24/2023Tia L BushInsiderSell8,000$4.48$35,840.00 (Data available from 1/1/2013 forward) CNTA Insider Trading Activity - Frequently Asked Questions Who is on Centessa Pharmaceuticals's Insider Roster? The list of insiders at Centessa Pharmaceuticals includes Aaron Kantoff, Antoine Yver, David J Grainger, David M Chao, Gregory M Weinhoff, Harris Rotman, Iqbal J Hussain, Karen M Anderson, Medicxi Ventures Management (J, Rubertis Francesco De, Saurabh Saha, Thomas Templeman, and Tia L Bush. Learn more on insiders at CNTA. What percentage of Centessa Pharmaceuticals stock is owned by insiders? 11.54% of Centessa Pharmaceuticals stock is owned by insiders. Learn more on CNTA's insider holdings. Which Centessa Pharmaceuticals insiders have been buying company stock? The following insider purchased CNTA shares in the last 24 months: Saurabh Saha ($46,300.00). How much insider buying is happening at Centessa Pharmaceuticals? Insiders have purchased a total of 10,000 CNTA shares in the last 24 months for a total of $46,300.00 bought. Which Centessa Pharmaceuticals insiders have been selling company stock? The following insiders have sold CNTA shares in the last 24 months: Antoine Yver ($558,344.03), David M Chao ($30,301.72), Gregory M Weinhoff ($35,638.95), Harris Rotman ($270,337.06), Iqbal J Hussain ($33,184.60), Karen M Anderson ($607,780.80), Thomas Templeman ($17,849.46), and Tia L Bush ($35,840.00). How much insider selling is happening at Centessa Pharmaceuticals? Insiders have sold a total of 253,433 Centessa Pharmaceuticals shares in the last 24 months for a total of $1,589,276.62 sold. More Insider Trading Tools from MarketBeat Related Companies: Innoviva Insider Transactions Liquidia Insider Transactions Zentalis Pharmaceuticals Insider Transactions Cassava Sciences Insider Transactions Immunome Insider Transactions OPKO Health Insider Transactions MacroGenics Insider Transactions Tyra Biosciences Insider Transactions 89bio Insider Transactions Arcutis Biotherapeutics Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1 This page (NASDAQ:CNTA) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersNo experience to confident trader, meet my student…Wealth Builders InstituteBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingRevealed: The Unknown Biotech Powering AI in HealthcareBehind the MarketsThe only accurate crypto trading system I know …Weiss RatingsOil Surge Predicted... But Are You ReadyThe Oxford ClubMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders Alliance Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centessa Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.